Rolls-Royce Holdings Plc:企業のM&A・事業提携・投資動向

◆英語タイトル:Rolls-Royce Holdings Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C0699
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:106
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:航空・防衛
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Rolls-Royce Holdings Plc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Rolls-Royce Holdings Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Rolls-Royce Holdings Plc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Rolls-Royce Holdings Plc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Rolls-Royce Holdings Plc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Rolls-Royce Holdings Plc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Rolls-Royce Holdings Plc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Rolls-Royce Holdings Plc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Rolls-Royce Holdings Plc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 44
Corporate Venturing – Overview 44
Corporate Venturing – Deal reports 45
PARTNERSHIP 48
Partnership – Overview 48
Partnership – Deal reports 49
CAPITAL RAISING 76
Capital Raising – Overview 76
Capital Raising – Deal reports 77
DIVESTMENTS 79
Divestments – Overview 79
Divestments – Deal reports 80
APPENDIX 96
Contact Us 96
About MarketLine Financial Deals Database 96
Deal Definition and Methodology 98
About MarketLine 105

List of Tables
Table 1: Rolls-Royce Holdings plc M&A volume and value trend (2014-YTD2018)
Table 2: Rolls-Royce Holdings plc M&A activity by geography (2014-YTD2018)
Table 3: Rolls-Royce Holdings plc corporate venturing volume and value trend (2014-YTD2018)
Table 4: Rolls-Royce Holdings plc corporate venturing by geography (2014-YTD2018)
Table 5: Rolls-Royce Holdings plc partnership volume and value trend (2014-YTD2018)
Table 6: Rolls-Royce Holdings plc partnership trend by key deal type (2014-YTD2018)
Table 7: Rolls-Royce Holdings plc capital raising volume and value trend (2014-YTD2018)
Table 8: Rolls-Royce Holdings plc capital raising by deal type (2014-YTD2018)
Table 9: Rolls-Royce Holdings plc divestments volume and value trend (2014-YTD2018)
Table 10: Rolls-Royce Holdings plc divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Rolls-Royce Holdings plc M&A volume and value trend (2014-YTD2018)
Figure 2: Rolls-Royce Holdings plc M&A activity by geography (2014-YTD2018)
Figure 3: Rolls-Royce Holdings plc corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Rolls-Royce Holdings plc corporate venturing by geography (2014-YTD2018)
Figure 5: Rolls-Royce Holdings plc partnership volume and value trend (2014-YTD2018)
Figure 6: Rolls-Royce Holdings plc partnership trend by key deal type (2014-YTD2018)
Figure 7: Rolls-Royce Holdings plc capital raising volume and value trend (2014-YTD2018)
Figure 8: Rolls-Royce Holdings plc capital raising by deal type (2014-YTD2018)
Figure 9: Rolls-Royce Holdings plc divestments volume and value trend (2014-YTD2018)
Figure 10: Rolls-Royce Holdings plc divestments by geography (2014-YTD2018)

★海外企業調査レポート[Rolls-Royce Holdings Plc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AnGes Inc (4563):企業の財務・戦略的SWOT分析
    AnGes Inc (4563) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Amplia Therapeutics Ltd (ATX):製薬・医療:M&Aディール及び事業提携情報
    Summary Amplia Therapeutics Ltd (Amplia Therapeutics), formerly Innate Therapeutics Ltd, is a pharmaceutical company with focus on the development of focal adhesion kinase (FAK) inhibitors for the treatment of cancer and fibrosis. Its lead drug candidate, AMP945, is a small molecule targeting focal …
  • STMicroelectronics N.V. (STM)-医療機器分野:企業M&A・提携分析
    Summary STMicroelectronics N.V. (ST) is a microelectronics company that designs, develops, manufactures, and markets a broad range of products for analog, digital, and mixed-signal applications. It offers standard commodity components, custom devices and semi-custom devices, application-specific int …
  • Jardine Engineering Corporation, Limited:企業の戦略・SWOT・財務情報
    Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report Summary Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Telekom Slovenije, d.d. (TLSG):企業の財務・戦略的SWOT分析
    Telekom Slovenije, d.d. (TLSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Applied DNA Sciences Inc (APDN):製薬・医療:M&Aディール及び事業提携情報
    Summary Applied DNA Sciences Inc (APDN) is a biotechnology company that provides DNA based security and authentication solutions and services. The company’s products comprise DNA security tools, DNA marking kit for assets and valuables, test kits, intruder and offender tagging systems; custom DNA se …
  • NCC AB:企業の戦略・SWOT・財務情報
    NCC AB - Strategy, SWOT and Corporate Finance Report Summary NCC AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Alta Mesa Resources Inc:企業の戦略的SWOT分析
    Alta Mesa Resources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Nektar Therapeutics (NKTR):企業の財務・戦略的SWOT分析
    Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • R Pharm-製薬・医療分野:企業M&A・提携分析
    Summary R Pharm is a pharmaceutical company that offers drug development and manufacturing. The company offers finished dosage forms, active pharmaceutical ingredients (api) and biotechnological substances. It provides products in therapeutic areas of oncology, hematology, immune diseases, antibioti …
  • Korea Research Institute of Chemical Technology:製薬・医療:M&Aディール及び事業提携情報
    Summary Korea Research Institute of Chemical Technology (KRICT) is a chemical institute that develops chemical process technologies. The institute provides green technology, chemical materials, drug candidates, and chemistry based fusion technologies. Its green chemistry research includes petroleum …
  • Glencore Plc:企業の戦略・SWOT・財務情報
    Glencore Plc - Strategy, SWOT and Corporate Finance Report Summary Glencore Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Superior Industries International Inc (SUP):企業の財務・戦略的SWOT分析
    Superior Industries International Inc (SUP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Epcor Utilities Inc:企業の戦略的SWOT分析
    Epcor Utilities Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Rocky Brands Inc (RCKY):企業の財務・戦略的SWOT分析
    Rocky Brands Inc (RCKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Kopin Corp (KOPN):企業の財務・戦略的SWOT分析
    Summary Kopin Corp (Kopin) is a technology company that offers wearable technologies and solutions. The company’s products comprise wearable headsets, transmissive liquid crystal displays, batteries, ASIC products, module products, whisper voice chip among others. Kopin technologies and solutions he …
  • Broncus Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Broncus Medical Inc (Broncus), formerly Broncus Technologies Inc is a medical device company that develops navigation, diagnostic and therapeutic technologies. The company’s products comprise lungpoint virtual bronchoscopic navigation system, lungpoint satellite planning system, and flexneed …
  • Avid Bioservices Inc (CDMO):製薬・医療:M&Aディール及び事業提携情報
    Summary Avid Bioservices Inc (Avid Bioservices), formerly Peregrine Pharmaceuticals Inc, is a biopharmaceutical company that develops, manufactures and markets monoclonal antibodies for the treatment and diagnosis of cancer. The company’s products include Bavituximab, PGN650 and Cotara. Its Bavituxi …
  • Weifa ASA (WEIFA)-石油・ガス分野:企業M&A・提携分析
    Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering p …
  • Freshfields Bruckhaus Deringer LLP:企業の戦略・SWOT・財務情報
    Freshfields Bruckhaus Deringer LLP - Strategy, SWOT and Corporate Finance Report Summary Freshfields Bruckhaus Deringer LLP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆